Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VRAY

ViewRay (VRAY) Stock Price, News & Analysis

ViewRay logo

About ViewRay Stock (NASDAQ:VRAY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.03
$0.65
52-Week Range
N/A
Volume
108.50 million shs
Average Volume
7.51 million shs
Market Capitalization
$4.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter.

VRAY Stock News Headlines

ViewRay Inc (VRAYQ) Earnings Dates & Reports
VRAY Jan 2025 2.000 call
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
VRAY Jan 2025 0.500 put
VRAY Jan 2025 0.500 call
VRAY Jan 2025 3.000 put
ViewRay Inc VRAYQ
NUBURU Appoints Brian Knaley as new CEO
See More Headlines

VRAY Stock Analysis - Frequently Asked Questions

ViewRay, Inc. (NASDAQ:VRAY) announced its quarterly earnings results on Monday, February, 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.01. The company's revenue for the quarter was up 70.1% compared to the same quarter last year.

The following companies are subsidiaries of ViewRay: Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc..

ViewRay (VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that ViewRay investors own include Alibaba Group (BABA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), NVIDIA (NVDA), Bristol Myers Squibb (BMY) and Amarin (AMRN).

Company Calendar

Last Earnings
2/27/2023
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VRAY
Employees
295
Year Founded
2004

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$107.33 million
Net Margins
-104.30%
Pretax Margin
-104.30%

Debt

Sales & Book Value

Annual Sales
$105.86 million
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
N/A

Miscellaneous

Free Float
178,817,000
Market Cap
$4.59 million
Optionable
Optionable
Beta
0.81

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:VRAY) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners